Home: PCU 4|2002: Faculty

Faculty of this educational activity will discuss published and/or investigational uses of agents that are not indicated by the FDA. The Postgraduate Institute for Medicine and NL Communications, Inc. do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

Faculty financial interests or affiliations

Leonard G Gomella, MD, FACS
Speakers’ Bureau: AstraZeneca Pharmaceuticals, LP

Peter R Carroll, MD
Does not have any financial interests or affiliations to disclose.

Peter T Scardino, MD
Grants/Research Support: National Cancer Institute
Stockholder: Proquest

A Oliver Sartor, BA, MD
Stockholder: Atrix Laboratories
Speakers’ Bureau: AstraZeneca Pharmaceuticals, LP; Schering-Plough Corporation

 
   

Home

Editor's Office

Editor’s Note:
Perceptions of treatment trade-offs in patients with prostate and breast cancer

Leonard G Gomella, MD, FACS
    - Select publications

Peter R Carroll, MD
    - Select publications

Peter T Scardino, MD
    - Select publications

A Oliver Sartor, BA, MD
    - Select publications

Faculty financial interests or affiliations

 
Terms of use and general disclaimer
© NL Communications, Inc. 2002. All rights reserved.